Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Parsons D, Joo M, Iqbal Z, Godley A, Kim N, Spangler A, Albuquerque K, Sawant A, Zhao B, Gu X, Rahimi A. Stability and reproducibility comparisons between deep inspiration breath-hold techniques for left-sided breast cancer patients: A prospective study. J Appl Clin Med Phys. 2023 May;24(5):e13906. doi: 10.1002/acm2.13906. Epub 2023 Jan 23. PubMed PMID: 36691339; PubMed Central PMCID: PMC10161105.
Johns C, Yen A, Rahimi A, Liu YL, Leitch AM, Spangler A, Alluri P, Nwachukwu C, Wooldridge R, Farr D, Kim DWN. Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients. J Breast Cancer. 2023 Feb;26(1):14-24. doi: 10.4048/jbc.2023.26.e3. Epub 2023 Jan 25. PubMed PMID: 36762783; PubMed Central PMCID: PMC9981985.
All S, Zhao B, Montalvo S, Maxwell C, Johns C, Gu X, Rahimi A, Alluri P, Parsons D, Chiu T, Schroeder S, Kim DN. Feasibility and efficacy of active breathing coordinator assisted deep inspiration breath hold technique for treatment of locally advanced breast cancer. J Appl Clin Med Phys. 2023 Feb;24(2):e13893. doi: 10.1002/acm2.13893. Epub 2022 Dec 31. PubMed PMID: 36585853; PubMed Central PMCID: PMC9924105.
Montalvo SK, Kim N, Nwachukwu C, Alluri P, Parsons D, Lin MH, Cai B, Zhuang T, Hrycushko B, Chen L, Timmerman R, Rahimi A. On the feasibility of improved target coverage without compromising organs at risk using online adaptive stereotactic partial breast irradiation (A-SPBI). J Appl Clin Med Phys. 2023 Feb;24(2):e13813. doi: 10.1002/acm2.13813. Epub 2022 Nov 9. PubMed PMID: 36350273; PubMed Central PMCID: PMC9924103.
Udden SMN, Baek G, Pandey K, Vidal C, Liu Y, Rahimi AS, Kim DN, Nwachukwu CR, Mani RS, Alluri PG. Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy. NPJ Precis Oncol. 2023 Jan 24;7(1):11. doi: 10.1038/s41698-023-00348-1. PubMed PMID: 36693944; PubMed Central PMCID: PMC9873388.
Rahimi A, Simmons A, Kim DN, Leitch M, Haas J, Gu X, Ahn C, Gao A, Spangler A, Morgan HE, Goudreau S, Seiler S, Farr D, Wooldridge R, Haley B, Bahrami S, Neufeld S, Mendez C, Alluri P, Rao R, Timmerman RD. In Reply to Hannoun-Levi et al. Int J Radiat Oncol Biol Phys. 2022 Jun 1;113(2):475-477. doi: 10.1016/j.ijrobp.2022.02.034. PubMed PMID: 35569485.
Hannan R, Salamekh S, Desai NB, Garant A, Folkert MR, Costa DN, Mannala S, Ahn C, Mohamad O, Laine A, Kim DWN, Dickinson T, Raj GV, Shah RB, Wang J, Jia X, Choy H, Roehrborn CG, Lotan Y, Timmerman RD. SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial. Int J Radiat Oncol Biol Phys. 2022 Jun 1;113(2):290-301. doi: 10.1016/j.ijrobp.2021.10.137. Epub 2021 Nov 11. PubMed PMID: 34774676; PubMed Central PMCID: PMC9091061.
Zhang-Velten E, Zhang Y, Radpour S, Gu X, Kim DN, Alluri P, Nwachukwu C, Chiu T, Lu W, Parsons D, Tan J, Gillespie J, Stevenson S, Choy H, Timmerman R, Rahimi A. A How-To Compendium for GammaPod Treatments, Clinical Workflow, and Clinical Program at an Early Adopting Institution. Pract Radiat Oncol. 2022 May-Jun;12(3):e177-e182. doi: 10.1016/j.prro.2022.01.006. Epub 2022 Feb 10. PubMed PMID: 35150897.
Rahimi A, Simmons A, Kim DN, Leitch M, Haas J, Gu X, Ahn C, Gao A, Spangler A, Morgan HE, Goudreau S, Seiler S, Farr D, Wooldridge R, Haley B, Bahrami S, Neufeld S, Mendez C, Alluri P, Rao R, Timmerman RD. Preliminary Results of Multi-Institutional Phase 1 Dose Escalation Trial Using Single-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):663-670. doi: 10.1016/j.ijrobp.2021.10.010. Epub 2021 Oct 25. PubMed PMID: 34710523.
Folkert MR, Zelefsky MJ, Hannan R, Desai NB, Lotan Y, Laine AM, Kim DWN, Neufeld SH, Hornberger B, Kollmeier MA, McBride S, Ahn C, Roehrborn C, Timmerman RD. A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer. Int J Radiat Oncol Biol Phys. 2021 Sep 1;111(1):101-109. doi: 10.1016/j.ijrobp.2021.03.025. Epub 2021 Mar 19. PubMed PMID: 33753140.
Kazemimoghadam M, Chi W, Rahimi A, Kim N, Alluri P, Nwachukwu C, Lu W, Gu X. Saliency-guided deep learning network for automatic tumor bed volume delineation in post-operative breast irradiation. Phys Med Biol. 2021 Aug 27;66(17). doi: 10.1088/1361-6560/ac176d. PubMed PMID: 34298539; PubMed Central PMCID: PMC8639319.
Rahimi A, Morgan HE, Kim DW, Zhang Y, Leitch M, Wooldridge R, Goudreau S, Haley B, Rao R, Rivers A, Spangler AE, Jones RT, Stevenson S, Staley J, Albuquerque K, Ahn C, Neufeld S, Alluri PG, Ding C, Garwood D, Seiler S, Zhao B, Gu X, Timmerman R. Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer. Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):772-782. doi: 10.1016/j.ijrobp.2021.01.015. Epub 2021 Jan 18. PubMed PMID: 33476737.
Rahimi A, Zhang Y, Kim DW, Morgan H, Hossain F, Leitch M, Wooldridge R, Seiler S, Goudreau S, Haley B, Rao R, Rivers A, Spangler A, Ahn C, Stevenson S, Staley J, Albuquerque K, Ding C, Gu X, Zhao B, Timmerman R. Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical Trial. Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):697-706. doi: 10.1016/j.ijrobp.2020.05.025. Epub 2020 May 26. PubMed PMID: 32464155.
Kim DW, Lee G, Lee H, Qian JM, Sanford NN, Lam MB, Tahir N, Mamon HJ. Stereotactic Body Radiation Therapy to a Splenic Metastasis in Oligoprogressive Non-small Cell Lung Cancer. Adv Radiat Oncol. 2020 May-Jun;5(3):516-521. doi: 10.1016/j.adro.2019.12.005. eCollection 2020 May-Jun. PubMed PMID: 32529149; PubMed Central PMCID: PMC7276683.
Rahimi A, Mohamad O, Albuquerque K, Kim DWN, Chen D, Thomas K, Wooldridge R, Rivers A, Leitch M, Rao R, Haley B, Ahn C, Garwood D, Spangler A. Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial. Support Care Cancer. 2020 Mar;28(3):1481-1489. doi: 10.1007/s00520-019-04957-0. Epub 2019 Jul 4. PubMed PMID: 31273506.
Yun EJ, Lin CJ, Dang A, Hernandez E, Guo J, Chen WM, Allison J, Kim N, Kapur P, Brugarolas J, Wu K, He D, Lai CH, Lin H, Saha D, Baek ST, Chen BPC, Hsieh JT. Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation. Clin Cancer Res. 2019 Jul 15;25(14):4542-4551. doi: 10.1158/1078-0432.CCR-18-3004. Epub 2019 Apr 18. PubMed PMID: 31000589; PubMed Central PMCID: PMC6635020.
Wardak Z, Bland R, Ahn C, Xie XJ, Chason D, Morrill K, Stehel E, Nedzi L, Ding C, Medin P, Boike T, Abdulrahman R, Folkert M, Iyengar P, Kim N, Choy H, Bagley C, Timmerman R. A Phase 2 Clinical Trial of SABR Followed by Immediate Vertebroplasty for Spine Metastases. Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):83-89. doi: 10.1016/j.ijrobp.2019.01.072. Epub 2019 Jan 23. PubMed PMID: 30684664.
Chen H, Chen M, Lu W, Zhao B, Jiang S, Zhou L, Kim N, Spangler A, Rahimi A, Zhen X, Gu X. Deep-learning based surface region selection for deep inspiration breath hold (DIBH) monitoring in left breast cancer radiotherapy. Phys Med Biol. 2018 Dec 12;63(24):245013. doi: 10.1088/1361-6560/aaf0d6. PubMed PMID: 30523967.
Chiu TD, Parsons D, Zhang Y, Hrycushko B, Zhao B, Chopra R, Kim N, Spangler A, Rahimi A, Timmerman R, Jiang SB, Lu W, Gu X. Prototype volumetric ultrasound tomography image guidance system for prone stereotactic partial breast irradiation: proof-of-concept. Phys Med Biol. 2018 Mar 1;63(5):055004. doi: 10.1088/1361-6560/aaad1f. PubMed PMID: 29405123.
Ying J, Wang CJ, Yan J, Liauw SL, Straka C, Pistenmaa D, Xie XJ, Lotan Y, Roehrborn C, Kim DN. Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy. Am J Clin Oncol. 2017 Dec;40(6):612-620. doi: 10.1097/COC.0000000000000207. PubMed PMID: 26165416.
Kim DWN, Medin PM, Timmerman RD. Emphasis on Repair, Not Just Avoidance of Injury, Facilitates Prudent Stereotactic Ablative Radiotherapy. Semin Radiat Oncol. 2017 Oct;27(4):378-392. doi: 10.1016/j.semradonc.2017.04.007. Review. PubMed PMID: 28865521.
Zhen X, Zhao B, Wang Z, Timmerman R, Spangler A, Kim N, Rahimi A, Gu X. Comprehensive target geometric errors and margin assessment in stereotactic partial breast irradiation. Radiat Oncol. 2017 Sep 11;12(1):151. doi: 10.1186/s13014-017-0889-6. PubMed PMID: 28893302; PubMed Central PMCID: PMC5594509.
Jones RT, Hassan Rezaeian N, Desai NB, Lotan Y, Jia X, Hannan R, Kim DWN, Hornberger B, Dubas J, Laine AM, Zelefsky MJ, Timmerman RD, Folkert MR. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials. Med Dosim. 2017 Winter;42(4):341-347. doi: 10.1016/j.meddos.2017.07.002. Epub 2017 Jul 31. PubMed PMID: 28774760.
Mohamad O, Sishc BJ, Saha J, Pompos A, Rahimi A, Story MD, Davis AJ, Kim DWN. Carbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/Repair. Cancers (Basel). 2017 Jun 9;9(6). doi: 10.3390/cancers9060066. Review. PubMed PMID: 28598362; PubMed Central PMCID: PMC5483885.
Wang CJ, Christie A, Lin MH, Jung M, Weix D, Huelsmann L, Kuhn K, Meyer J, Desai N, Kim DWN, Pedrosa I, Margulis V, Cadeddu J, Sagalowsky A, Gahan J, Laine A, Xie XJ, Choy H, Brugarolas J, Timmerman R, Hannan R. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases. Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):91-100. doi: 10.1016/j.ijrobp.2017.01.032. PubMed PMID: 28587057; PubMed Central PMCID: PMC5555369.
Shiao J, Thomas KM, Rahimi AS, Rao R, Yan J, Xie XJ, DaSilva M, Spangler A, Leitch M, Wooldridge R, Rivers A, Farr D, Haley B, Kim DW. Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients. Breast Cancer Res Treat. 2017 Feb;161(3):463-471. doi: 10.1007/s10549-016-4081-8. Epub 2016 Dec 22. PubMed PMID: 28005245.
Kim DN, Straka C, Cho LC, Lotan Y, Yan J, Kavanagh B, Raben D, Cooley S, Brindle J, Xie XJ, Pistenmaa D, Timmerman R. Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial. Pract Radiat Oncol. 2017 Jan-Feb;7(1):e43-e49. doi: 10.1016/j.prro.2016.06.010. Epub 2016 Jun 24. PubMed PMID: 27637137.
Hannan R, Tumati V, Xie XJ, Cho LC, Kavanagh BD, Brindle J, Raben D, Nanda A, Cooley S, Kim DWN, Pistenmaa D, Lotan Y, Timmerman R. Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial. Eur J Cancer. 2016 May;59:142-151. doi: 10.1016/j.ejca.2016.02.014. Epub 2016 Mar 29. PubMed PMID: 27035363.
Straka C, Ying J, Kong FM, Willey CD, Kaminski J, Kim DW. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus. 2016;5:229. doi: 10.1186/s40064-016-1900-7. eCollection 2016. Review. PubMed PMID: 27026923; PubMed Central PMCID: PMC4771672.
Wang CJ, Ying J, Kapur P, Wohlfeld B, Roehrborn C, Kim DW. Solitary recurrence of castration-resistant prostate cancer with low or undetectable levels of prostate specific antigen salvaged with local ablative radiation therapy: A case report. Oncol Lett. 2016 Jan;11(1):713-716. doi: 10.3892/ol.2015.3940. Epub 2015 Nov 18. PubMed PMID: 26870272; PubMed Central PMCID: PMC4727102.
Jacobs C, Tumati V, Kapur P, Yan J, Xie XJ, Hannan R, Hsieh JT, Kim DW, Saha D. Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high-risk prostate cancer patients with worse survival following radiation therapy. Cancer Med. 2015 Dec;4(12):1844-52. doi: 10.1002/cam4.554. Epub 2015 Oct 16. PubMed PMID: 26471467; PubMed Central PMCID: PMC4940806.
Huelsmann L, Kim DNW, Hannan R, Watumull LM, Brugarolas J. Selective Efficacy of Temsirolimus on Bone Metastases in Chromophobe Renal Cell Carcinoma. Clin Genitourin Cancer. 2015 Aug;13(4):e321-e323. doi: 10.1016/j.clgc.2014.12.007. Epub 2014 Dec 20. PubMed PMID: 25620636.
Law JY, Kim DW, Sturgis A, Naina HV. Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab. Clin Med Insights Oncol. 2015;9:61-3. doi: 10.4137/CMO.S27142. eCollection 2015. PubMed PMID: 26157340; PubMed Central PMCID: PMC4489670.
Hannan R, Margulis V, Chun SG, Cannon N, Kim DW, Abdulrahman RE, Sagalowsky A, Pedrosa I, Choy H, Brugarolas J, Timmerman RD. Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus. Cancer Biol Ther. 2015;16(5):657-61. doi: 10.1080/15384047.2015.1026506. PubMed PMID: 25800036; PubMed Central PMCID: PMC4622024.
Kim DW, Straka C, Cho LC, Timmerman RD. Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study. Front Oncol. 2014;4:319. doi: 10.3389/fonc.2014.00319. eCollection 2014. PubMed PMID: 25505731; PubMed Central PMCID: PMC4245005.
Arreola KN, Ying J, Hughes R, Gerber DE, Kim DW. Intramedullary spinal cord hemorrhage after treatment with bevacizumab in a long-term survivor with metastatic non-small-cell lung cancer. J Thorac Oncol. 2014 Aug;9(8):e60-1. doi: 10.1097/JTO.0000000000000172. PubMed PMID: 25157780.
Jacobs C, Tumati V, Kapur P, Yan J, Hong D, Bhuiyan M, Xie XJ, Pistenmaa D, Yu L, Hsieh JT, Saha D, Kim DW. DOC-2/DAB2 interacting protein status in high-risk prostate cancer correlates with outcome for patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):729-35. doi: 10.1016/j.ijrobp.2014.03.035. Epub 2014 May 24. PubMed PMID: 24867541; PubMed Central PMCID: PMC4464555.
Kim DW, Cho LC, Straka C, Christie A, Lotan Y, Pistenmaa D, Kavanagh BD, Nanda A, Kueplian P, Brindle J, Cooley S, Perkins A, Raben D, Xie XJ, Timmerman RD. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):509-17. doi: 10.1016/j.ijrobp.2014.03.012. PubMed PMID: 24929162.
Jacobs CD, Chun SG, Yan J, Xie XJ, Pistenmaa DA, Hannan R, Lotan Y, Roehrborn CG, Choe KS, Kim DW. Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy. Cancer Biol Ther. 2014 Jun 1;15(6):699-706. doi: 10.4161/cbt.28554. Epub 2014 Mar 21. PubMed PMID: 24658086; PubMed Central PMCID: PMC4049786.
Straka C, Kim DW, Timmerman RD, Pedrosa I, Jacobs C, Brugarolas J. Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months. J Clin Oncol. 2013 Aug 10;31(23):e401-3. doi: 10.1200/JCO.2012.47.7455. Epub 2013 Jun 24. PubMed PMID: 23796996; PubMed Central PMCID: PMC4878052.
Yu L, Tumati V, Tseng SF, Hsu FM, Kim DN, Hong D, Hsieh JT, Jacobs C, Kapur P, Saha D. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor. Neoplasia. 2012 Dec;14(12):1203-12. doi: 10.1593/neo.121310. PubMed PMID: 23308052; PubMed Central PMCID: PMC3540945.
Kim DN, Nam TK, Choe KS, Choy H. Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer. Cancer Res Treat. 2012 Jun;44(2):74-84. doi: 10.4143/crt.2012.44.2.74. Epub 2012 Jun 30. PubMed PMID: 22802745; PubMed Central PMCID: PMC3394867.
Huamani J, Willey C, Thotala D, Niermann KJ, Reyzer M, Leavitt L, Jones C, Fleishcher A, Caprioli R, Hallahan DE, Kim DW. Differential efficacy of combined therapy with radiation and AEE788 in high and low EGFR-expressing androgen-independent prostate tumor models. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):237-46. doi: 10.1016/j.ijrobp.2007.12.049. Epub 2008 Mar 11. PubMed PMID: 18337021; PubMed Central PMCID: PMC2441843.
Niermann KJ, Fleischer AC, Huamani J, Yankeelov TE, Kim DW, Wilson WD, Hallahan DE. Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. J Ultrasound Med. 2007 Jun;26(6):749-56. doi: 10.7863/jum.2007.26.6.749. PubMed PMID: 17526606.
Kim DW, Huamani J, Niermann KJ, Lee H, Geng L, Leavitt LL, Baheza RA, Jones CC, Tumkur S, Yankeelov TE, Fleischer AC, Hallahan DE. Noninvasive assessment of tumor vasculature response to radiation-mediated, vasculature-targeted therapy using quantified power Doppler sonography: implications for improvement of therapy schedules. J Ultrasound Med. 2006 Dec;25(12):1507-17. doi: 10.7863/jum.2006.25.12.1507. PubMed PMID: 17121945.
Yankeelov TE, Niermann KJ, Huamani J, Kim DW, Quarles CC, Fleischer AC, Hallahan DE, Price RR, Gore JC. Correlation between estimates of tumor perfusion from microbubble contrast-enhanced sonography and dynamic contrast-enhanced magnetic resonance imaging. J Ultrasound Med. 2006 Apr;25(4):487-97. doi: 10.7863/jum.2006.25.4.487. PubMed PMID: 16567438.
Kim DW, Huamani J, Fu A, Hallahan DE. Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):38-46. doi: 10.1016/j.ijrobp.2005.02.008. PubMed PMID: 16377414.
Kim DW, Shyr Y, Chen H, Akerley W, Johnson DH, Choy H. Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1029-36. doi: 10.1016/j.ijrobp.2005.03.055. PubMed PMID: 15913910.
Kim DW, Shyr Y, Shaktour B, Akerley W, Johnson DH, Choy H. Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer. Lung Cancer. 2005 Nov;50(2):235-45. doi: 10.1016/j.lungcan.2005.05.020. Epub 2005 Jul 25. PubMed PMID: 16043262.
Kim DW, Lu B, Hallahan DE. Receptor tyrosine kinase inhibitors as anti-angiogenic agents. Curr Opin Investig Drugs. 2004 Jun;5(6):597-604. Review. PubMed PMID: 15242247.
What would you like to do?